Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Austin, Texas


Purpose:

This study will evaluate the safety, tolerability, and pharmacokinetics of ALKS 8700, a monomethyl fumerate (MMF) molecule.


Criteria:

Inclusion Criteria: - Has a body-mass Index (BMI) >/=18.0 and </=32.0 kg/m2 - Agrees to use an acceptable method of contraception for the duration of the study and for 30 days after any study drug administration - Additional criteria may apply Exclusion Criteria: - Is currently pregnant or breastfeeding - Has a lifetime history of menopausal hot flashes - Has a clinically significant medical condition - Has had a clinically significant illness in the 30 days prior to first study drug administration - Has had a serious infection (eg, pneumonia or septicemia) within the 3 months prior to study drug administration - Has had any vaccinations in the 4 weeks prior to inpatient admission - Has a lifetime history of diabetes - Additional criteria may apply


NCT ID:

NCT02201849


Primary Contact:

Study Director
Richard Leigh-Pemberton, MD
Alkermes, Inc.


Backup Contact:

N/A


Location Contact:

Austin, Texas
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 20, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.